Colgate-Palmolive Company $CL Stock Purchased by Kintegral Advisory LLC

Kintegral Advisory LLC raised its holdings in Colgate-Palmolive Company (NYSE:CL) by 203.2% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 48,169 shares of the company’s stock after purchasing an additional 32,284 shares during the quarter. Kintegral Advisory LLC’s holdings in Colgate-Palmolive were worth $4,110,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Cooper Financial Group raised its holdings in shares of Colgate-Palmolive by 4.0% in the second quarter. Cooper Financial Group now owns 2,947 shares of the company’s stock valued at $270,000 after buying an additional 114 shares during the last quarter. Gould Capital LLC grew its holdings in Colgate-Palmolive by 38.7% during the 1st quarter. Gould Capital LLC now owns 412 shares of the company’s stock worth $35,000 after acquiring an additional 115 shares during the last quarter. Redhawk Wealth Advisors Inc. grew its holdings in Colgate-Palmolive by 2.8% during the 2nd quarter. Redhawk Wealth Advisors Inc. now owns 4,326 shares of the company’s stock worth $397,000 after acquiring an additional 118 shares during the last quarter. SVB Wealth LLC increased its position in Colgate-Palmolive by 1.4% in the 2nd quarter. SVB Wealth LLC now owns 8,767 shares of the company’s stock valued at $804,000 after acquiring an additional 119 shares in the last quarter. Finally, ANB Bank increased its position in Colgate-Palmolive by 1.7% in the 1st quarter. ANB Bank now owns 7,200 shares of the company’s stock valued at $614,000 after acquiring an additional 120 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Insiders Place Their Bets

In other Colgate-Palmolive news, CEO Noel Wallace sold 161,021 shares of the company’s stock in a transaction on Tuesday, August 4th. The shares were sold at an average price of $91.92, for a total transaction of $14,801,050.32. Following the completion of the sale, the chief executive officer owned 362,231 shares in the company, valued at approximately $33,296,273.52. The trade was a 30.77% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director John Cahill sold 4,170 shares of the company’s stock in a transaction on Thursday, August 6th. The shares were sold at an average price of $93.37, for a total transaction of $389,352.90. Following the sale, the director owned 28,373 shares of the company’s stock, valued at $2,649,187.01. The trade was a 12.81% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 175,191 shares of company stock valued at $16,110,903. Company insiders own 0.43% of the company’s stock.

Colgate-Palmolive Trading Up 1.5%

Colgate-Palmolive stock traded up $1.35 during trading hours on Friday, reaching $94.02. 5,775,087 shares of the company’s stock traded hands, compared to its average volume of 5,409,072. The firm has a market capitalization of $74.95 billion, a price-to-earnings ratio of 37.31, a PEG ratio of 4.43 and a beta of 0.33. The company has a debt-to-equity ratio of 13.82, a quick ratio of 0.67 and a current ratio of 1.03. Colgate-Palmolive Company has a fifty-two week low of $74.54 and a fifty-two week high of $99.33. The firm’s 50 day moving average is $89.05 and its 200-day moving average is $89.02.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, July 31st. The company reported $0.99 EPS for the quarter, topping the consensus estimate of $0.95 by $0.04. The company had revenue of $5.36 billion during the quarter, compared to analysts’ expectations of $5.36 billion. Colgate-Palmolive had a net margin of 9.68% and a return on equity of 464.63%. Colgate-Palmolive’s revenue was up 4.9% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.92 EPS. On average, analysts predict that Colgate-Palmolive Company will post 3.87 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Tuesday, October 20th will be issued a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date of this dividend is Tuesday, October 20th. Colgate-Palmolive’s payout ratio is currently 84.13%.

Analyst Ratings Changes

CL has been the topic of a number of research reports. TD Cowen upped their target price on shares of Colgate-Palmolive from $85.00 to $90.00 and gave the stock a “hold” rating in a research report on Monday, August 3rd. Barclays raised their price target on shares of Colgate-Palmolive from $80.00 to $87.00 and gave the company an “equal weight” rating in a report on Tuesday, July 21st. Weiss Ratings cut shares of Colgate-Palmolive from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Friday, October 2nd. Raymond James Financial upped their price objective on Colgate-Palmolive from $100.00 to $102.00 and gave the stock an “outperform” rating in a report on Monday, August 3rd. Finally, Morgan Stanley reiterated an “overweight” rating and issued a $104.00 price objective (up from $100.00) on shares of Colgate-Palmolive in a research report on Monday, August 3rd. Thirteen equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $97.95.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwashes, body washes, deodorants, soaps, household cleaning products and pet food and treats.

The company markets many of its products under well-known brands, including Colgate, Palmolive, elmex, meridol, Protex, Softsoap, Ajax, Irish Spring, Speed Stick, Tom’s of Maine and Hill’s Science Diet.